Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T cell receptor alpha joining 16 (TRAJ16)
- Target
- TRAJ16
- Molecular classification
- Joining gene segment, Immunoglobulin superfamily, Component of T cell receptor alpha chain
01
Overview
TRAJ16 encodes a joining segment of the T cell receptor alpha chain, participating in V(D)J recombination to generate diversity in the T cell receptor's antigen-binding site. This gene segment contributes to the specificity of T cell receptors that recognize peptide antigens presented by major histocompatibility complex (MHC) molecules. While essential for the normal assembly and function of T cell receptors and the adaptive immune response, TRAJ16 is not a direct therapeutic target, nor is it used in drug development or in biomarker strategies. If you need information about the entire T cell receptor alpha chain (TCRA) or the T cell receptor molecule as a therapeutic target, please specify, as those are distinct and relevant drug targets in immunotherapy.
- Other names
- TRAJ16TCR-alpha J16
02
Mechanism of action
no distinct mechanism—THERAPEUTIC drugs do not interact with TRAJ16
03
Biological functions
Lymphocyte antigen recognition/diversificationAdaptive immune response
04
Disease associations
Other (no direct roles; aberrations in TCR recombination can influence immunity or immune disorders, but TRAJ16 is not specifically implicated)
Beyond the preview
Go deeper on T cell receptor alpha joining 16 (TRAJ16).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on T cell receptor alpha joining 16 (TRAJ16).